Read this first.
This guide is general background. It is not legal advice, it does not state the requirements of any particular state, and requirements change frequently. Confirm your own position with your state medical board, your state nursing board, and a healthcare attorney licensed in your state before acting.
The short answer
Injecting a neuromodulator involves two separate authorities: who may assess a patient and order the treatment, and who may administer it. Physicians may do both. Nurse practitioners and physician assistants generally may, subject to state rules. Registered nurses may usually administer but never order — and only after a qualified prescriber has examined the patient.
Quick answers
Six narrow questions, one sentence each. These catch conversational queries that don’t warrant reading the article. Phrased deliberately differently from the FAQ at the bottom, and not included in the FAQPage schema.
Can a registered nurse inject a neuromodulator? In most states yes, under delegation from a qualified prescriber and only after that prescriber has examined the patient.
Can a medical assistant or esthetician inject? Generally not — injectables sit outside their scope in the large majority of states, whatever training a manufacturer or private course has provided.
Does a training certificate authorise anyone to inject? No — a certificate demonstrates training, and authority comes from your licence and your state’s delegation rules.
Can the prescriber be somewhere else during the treatment? Sometimes, and it depends entirely on your state’s supervision requirements, which range from on-site presence to remote availability.
Does a standing order cover a new patient? Generally not — standing orders typically cover follow-up treatment under an established protocol rather than the first assessment of a new patient.
Do the same rules apply to dermal filler? Broadly yes — filler is prescription-classified in the US, and the ordering and delegation framework applies in the same way.
Key takeaways
- Ordering and administering are two distinct authorities, and confusing them is the most common compliance failure in medical aesthetics.
- The good faith examination is what connects them — without it, the delegation has nothing to rest on.
- A registered nurse can administer under delegation but cannot prescribe or independently assess a new patient, in any state.
- Supervision requirements vary from physical presence to remote availability, and getting the proximity wrong can render treatments unauthorised.
- Injectable scope drift — providers doing more than their delegation covers — is one of the defects buyers find most reliably in diligence.
The two questions that get confused
Almost every scope-of-practice mistake in medical aesthetics comes from treating “who can inject” as one question. It is two.
Who may assess the patient and order the treatment? This is a prescribing function. It requires prescriptive authority.
Who may administer the product? This is an administration function. It requires a licence permitting it, plus valid delegation where the administering provider is not the prescriber.
A practice can have the second right and the first wrong, and frequently does. The injector is properly licensed, appropriately trained, technically excellent — and the treatment is still unauthorised because nobody with prescriptive authority assessed the patient first.
A note on terminology: Botox is a brand of botulinum toxin type A owned by Allergan Aesthetics, an AbbVie company. The rules described here apply to neuromodulators as a category, not to one product, and this article uses the general term throughout.
Who may order, and who may administer
The table below describes the general framework across US states. It is a framework, not an answer. Every cell has state-level variation behind it, and several have significant variation.
| Provider | May assess and order | May administer |
|---|---|---|
| Physician (MD/DO) | Yes, in every state | Yes |
| Nurse practitioner | Usually, subject to state practice authority and any collaboration requirement | Yes |
| Physician assistant | Generally, within delegated scope and supervising-physician protocols | Yes |
| Registered nurse | No | Yes, under valid delegation, after a good faith examination |
| LPN / LVN | No | Narrower than RN authority, and varies considerably by state |
| Medical assistant | No | Generally not for injectables |
| Esthetician / aesthetician | No | Generally not for injectables |
Two rows deserve expansion, because they account for most of the confusion.
Registered nurses
An RN may administer injectables in most states. An RN may not prescribe, and may not perform the initial assessment that authorises the treatment, anywhere.
This is not a technicality about paperwork. The assessment is a clinical judgement about whether a prescription-classified product is appropriate for this patient — medical history, contraindications, expectations, anatomy. That judgement sits with a prescriber.
An RN-owned or RN-operated practice therefore always depends on a prescriber relationship. That dependency is structural, and buyers examine it as one.
Medical assistants and estheticians
Injectables sit outside these scopes in the large majority of states.
The recurring source of trouble is training rather than licensure. Manufacturer courses and private academies issue certificates, and a certificate feels like authority. It is not. Training demonstrates competence; your licence and your state’s delegation rules determine authority. A practice that has allowed an unlicensed or differently-licensed team member to inject because they attended a course has a problem that training cannot cure retrospectively.
The good faith examination
The link between the two authorities, and the single most important operational item in this article.
A good faith examination is an individualised assessment of the patient by a qualified prescriber before a prescription-classified treatment is ordered. It establishes that the treatment is appropriate for this specific person, and it is what a delegation to an administering provider rests on.
The failure pattern
It is widespread and it is simple.
A registered nurse treats a first-time patient. The nurse is licensed. The product is properly sourced and stored. A delegation order exists as a document in the file.
And the chain fails, because the examination that authorises it did not happen.
Three details that recur
A delegation order does not replace the examination. The order becomes valid once the examination is complete. It should be specific to that patient and that treatment rather than a reusable form applied across a patient base.
The requirement extends beyond neuromodulators. Dermal fillers and other prescription-classified injectables generally carry the same requirement. Practices frequently treat filler as lower risk on the assumption that it is cosmetic rather than medical; the classification says otherwise.
Telehealth is accepted in some states, conditionally. Several states permit the examination to be conducted by live, synchronous encounter. A form completed without real-time provider interaction typically does not satisfy the requirement.
Whether your state accepts a telehealth examination, and on what terms, is a matrix question rather than a general one.
What “supervised” actually means
Supervision is not one thing. States define it differently, and the differences are operationally significant.
The range runs roughly from a supervising physician who must be physically present on the premises, through one who must be immediately available by telephone or video, to one who must simply be reachable and identifiable as responsible.
Three practical consequences.
Proximity requirements affect staffing, not just paperwork. A state requiring on-site presence means the practice cannot operate injectable appointments when the prescriber is absent. Practices sometimes discover this after building a schedule that assumes otherwise.
“Available” needs a definition. Available by phone within what period? Able to attend within what time? If your protocol does not say, a regulator or a buyer’s counsel will ask what it meant in practice.
The requirement follows the treatment, not the building. A prescriber’s availability has to hold for every treatment performed, including evenings, weekends and any additional location.
Standing orders and their limits
A standing order is a written protocol permitting an authorised provider to administer a treatment without individual sign-off on each occasion.
They are legitimate and useful. They also have a boundary that practices routinely overrun.
A standing order generally covers follow-up treatment for an established patient under an existing protocol — a maintenance appointment for someone already assessed, treated, and known to the practice.
It generally does not substitute for the individual assessment of a new patient, or for reassessment where something material has changed: a new medical condition, a new medication, a pregnancy, an adverse reaction, or a request for a different treatment from the one originally assessed.
The test worth applying internally: could the prescriber who wrote this order have anticipated this specific patient, on this specific day, for this specific treatment? Where the honest answer is no, the standing order is doing work it was not designed for.
Where practices most often get this wrong
Five patterns, in roughly the order they appear in a compliance review.
1. Missing examinations for new patients. The most common finding, and the one that attaches to historical treatments rather than just to current practice.
2. Reusable delegation orders. A single signed form applied across a patient base rather than orders specific to patient and treatment.
3. Scope drift as the menu expands. A practice adds a treatment, a provider begins performing it, and nobody checks whether the delegation or the licence covers it. This happens quietly over years.
4. Certificate-based authority. A team member injecting because they completed a training course rather than because their licence and state rules permit it.
5. Supervision that exists on paper. A named supervising prescriber who is not actually available on the terms the state requires, with no records demonstrating that they were.
Each of these is fixable going forward. None of them is fixable retrospectively — which matters for the section below.
Why any of this affects what a practice is worth
Most readers of this page are not selling anything, and this section is short for that reason. But it is the reason a publication about transactions covers scope of practice at all.
Injectable authority is examined in legal diligence. A buyer’s counsel maps every provider against every treatment they perform, checks it against licences and delegation records, and samples good faith examination documentation across the patient file.
What they find changes the deal in a particular way. Compliance defects tend not to produce a proportionate price reduction — they produce specific indemnity carve-outs, often uncapped, a holdback pending remediation, or an extended timeline. Occasionally they end a transaction, because some institutional buyers will not acquire historical exposure they cannot quantify.
The asymmetry is the point. A gap identified today is a process change. The same gap identified during exclusivity is a liability the buyer inherits, and they will price it or refuse it.
The wider picture is in CPOM and MSO structures, and the preparation sequence in preparing a med spa for sale.
Frequently asked questions
Who can inject Botox? Physicians may assess, order and administer neuromodulators in every state. Nurse practitioners and physician assistants generally may, subject to state practice authority and supervision rules. Registered nurses may usually administer under delegation, but only after a qualified prescriber has examined the patient.
Can a registered nurse inject Botox? In most states, yes — under valid delegation from a qualified prescriber and following a good faith examination of the patient. An RN cannot prescribe and cannot perform the initial assessment that authorises the treatment.
Can a medical assistant inject Botox? Generally not. Injectables sit outside the medical assistant scope in the large majority of states, and completing a manufacturer or private training course does not change that.
Does a nurse need a doctor present to inject? It depends on your state’s supervision requirements, which range from physical presence on the premises to remote availability. The requirement applies to every treatment performed, including outside normal hours.
What is a good faith examination? An individualised assessment of the patient by a qualified prescriber before a prescription-classified treatment is ordered. It establishes that the treatment is appropriate for that specific patient, and it is what any delegation to an administering provider rests on.
Do the same rules apply to dermal filler? Broadly, yes. Dermal fillers are prescription-classified in the US, and the ordering, examination and delegation framework applies in the same way — though practices frequently treat filler as lower risk than neuromodulators.
Does a training certificate let me inject? No. Training demonstrates competence. Authority comes from your professional licence and from your state’s delegation and supervision rules, and no certificate can extend a scope of practice.
